{
    "2021-09-03": [
        [
            {
                "time": "",
                "original_text": "A股异动 | 贝达药业(300558.SZ)大涨10% 拟推2021年限制性股票激励计划",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "大涨",
                        "限制性股票激励计划"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国盛证券维持贝达药业买入评级：未来五年有望加速增长，股权激励体现公司十足信心",
                "features": {
                    "keywords": [
                        "国盛证券",
                        "买入评级",
                        "加速增长",
                        "股权激励"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跟踪报告：创新药系列研究 PD-1/L1普药化 国内IO市场如何演绎",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "PD-1/L1",
                        "普药化",
                        "国内IO市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}